Gene therapy biotech Homology Medicines files for a $100 million IPO – Nasdaq
Nasdaq |
Gene therapy biotech Homology Medicines files for a $100 million IPO
Nasdaq Homology Medicines, a preclinical biotech developing a gene therapy delivery platform for rare diseases, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The Bedford, MA-based company was founded in 2015 and plans … |
